Also known as آسٹیوپوروسس مینجمنٹ
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS (Family Medicine)
Internal Medicine Specialist
MBBS, MCPS Family Medicine
Family Physician
M.B.B.S, M.C.P.S (Medicine)
General Physician
M.B.B.S., MRCGP (UK)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
MBBS, FCPS (Medicine)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Internal Medicine Specialist
B.Sc, M.B.B.S., Certification in Diabetes , F.C.P.S (Medicine), MACP (USA), Fellow of Gastroenterology, MRCP 1 & 2 UK, MACG(USA)
Rheumatologist
MBBS, MRCP (UK), FCPS (Medicine), FCPS (Rheumatology), Long Course of Connective Tissue Diseases
Rheumatologist
MBBS, MRCP (UK), FCPS (Medicine), FCPS (Rheumatology), Long Course of Connective Tissue Diseases
Internal Medicine Specialist
M.B.B.S., F.C.P.S.
Bisphosphonates are used as first-line pharmacologictreatment for osteoporosis. In patients who cannot tolerate or whose symptoms do not improve with bisphosphonate therapy, teriparatide (Forteo) and denosumab (Prolia) are effective alternative medications to prevent osteoporotic fractures